Image source: ACADIA Pharmaceuticals.
What: Shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharma focused on diseases of the central nervous system, were up more than 12% as of 3:30 p.m. ET on rumors that AstraZeneca PLC (ADR) (NYSE: AZN) is eyeing the company as a potential acquisition candidate.